Susceptibility of Neisseria meningitidis to 16 Antimicrobial Agents and Characterization of Resistance Mechanisms Affecting Some Agents
Open Access
- 1 July 2005
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 43 (7) , 3162-3171
- https://doi.org/10.1128/jcm.43.7.3162-3171.2005
Abstract
Neisseria meningitidis represents a pathogen of great public health importance in both developed and developing countries. Resistance to some antimicrobial agents used either for therapy of invasive infections or for prophylaxis of case contacts has long been recognized, although specific guidelines for susceptibility testing have not been fully developed. We have examined the susceptibilities of a collection of 442 meningococcal clinical isolates from 15 countries to 16 antimicrobial agents. These included isolates recovered between 1917 and 2004, with representatives of all major serogroups. All isolates were tested by the Clinical and Laboratory Standards Institute (formerly NCCLS) broth microdilution method using Mueller-Hinton lysed horse blood broth, while a subset of 102 isolates was tested by agar dilution using Mueller-Hinton sheep blood agar. Most isolates provided adequate growth for MIC determinations by both broth and agar methods. Growth in broth was enhanced by CO 2 incubation and was required for two strains (1.7%). MICs of the study drugs compared favorably between the broth and agar methods (79 to 100% essential agreement), and MICs also generally agreed closely (92 to 100% essential agreement, excluding azithromycin) between broth tests incubated in the two different atmospheres. Elevated penicillin and ampicillin MICs (≥0.12 μg/ml and ≥0.25 μg/ml, respectively) occurred in 14.3% and 8.6% of strains and were associated with polymorphisms of the penA gene encoding a modified penicillin-binding protein 2. None of the 442 isolates produced beta-lactamase. Elevated tetracycline and doxycycline (but not minocycline) MICs were associated with efflux-mediated resistance encoded by tet (B) in 13 strains. Resistance to sulfisoxazole in 21.7% of strains and to trimethoprim-sulfamethoxazole in 21.0% resulted from polymorphisms of folP encoding a modified dihydropteroate synthetase. Seven strains were resistant to rifampin due to mutations in the rpoB gene, and two strains were resistant to chloramphenicol due to production of chloramphenicol acetyltransferase mediated by catP . Two strains had reduced quinolone susceptibility due to mutations of gyrA . The determination of the susceptibilities of a large group of meningococcal strains (including strains with characterized resistance mechanisms) to 16 antimicrobial agents has served as the essential first step in defining susceptibility testing breakpoints specific for this organism.Keywords
This publication has 37 references indexed in Scilit:
- International Clone of Neisseria meningitidis Serogroup A with Tetracycline Resistance Due to tet (B)Antimicrobial Agents and Chemotherapy, 2005
- Mutations in folP Associated with Elevated Sulfonamide MICs for Neisseria meningitidis Clinical Isolates from Five ContinentsAntimicrobial Agents and Chemotherapy, 2005
- Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971–1999Pathology, 2004
- PCR and Restriction Endonuclease Assay for Detection of a Novel Mutation Associated with Sulfonamide Resistance in Neisseria meningitidisAntimicrobial Agents and Chemotherapy, 2003
- Nonculture Prediction of Neisseria meningitidis Susceptibility to PenicillinAntimicrobial Agents and Chemotherapy, 2001
- Neisseria meningitidis: evolution of penicillin resistance and phenotype in a children's hospital in Barcelona, SpainActa Paediatrica, 2000
- Statement of Editorial Policy: Clinical Infectious DiseasesClinical Infectious Diseases, 1997
- Meningitis due toNeisseria meningitidis with intermediate susceptibility to penicillinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxisThe Lancet, 1993
- Penicillin-resistant beta-lactamase producingNeisseria meningitidis in SpainEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989